drugset / Trial / NCT01732094
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the present study is to examine the level of ovarian response and the pregnancy rates among poor ovarian responders treated with a novel treatment protocol with 150μg corifollitropin alfa followed by 300IU hMG in a long GnRH agonist protocol.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Corifollitropin alfa | Protein / enzyme biologic | 150 ug | — |
| Subject | Menopur | Protein / enzyme biologic | 300 iu | — |
| Background | Triptorelin | Other / unclassified | 0.1 mg | — |